Nicht spezifische Behandlungseffekte – Bedeutung in der Reisemedizin

Jede medizinische Intervention ist von nicht spezifischen Wirkungen begleitet. So wirken sich sicherheitsvermittelnde Vorstellungen wie religiöser Glaube oder Spiritualität und eine gute Einnahmedisziplin per se positiv auf den Gesundheitszustand des Patienten aus. Die hirnphysiologischen Zusammenhänge nicht spezifischer Effekte sind zunehmend gut untersucht. Ein besseres Verständnis kann auch in der Reisemedizin helfen, die Qualität rationaler, evidenzbasierter, überprüfbarer Beratung und Behandlung im Interesse des Patienten weiter zu verbessern.

Every medical intervention is accompanied by non-specific effects. A favorable effect on the patient's well-being is exercised by a feeling of safety conveyed by religious belief or spirituality and a good patient discipline of regular intake. Medical researchers have increasingly explored the brain-physiological effects of non-specific influences exercised by external circumstances. If these interactions are better realised, travel medicine will benefit by an improved quality of rational and evidence-based patient advice and treatment.

Key words

travel medicine - non-specific effects - placebo - advice

Literatur

• 1 Grunbaum A. The placebo concept in medicine and psychiatry.  Psychol Med. 16;  19-38
• 2 Hróbjartsson A. Clinical placebo interventions are unethical, unnecessary, and unprofessional.  J Clin Ethics. 2008;  19 66-69
• 3 Windeler J. Placebo-Effekte.  Z Arztl Fortbild Qualitatssich. 2007;  101 307-312
• 4 Nunn R. It's time to put the Placebo out of our misery.  BMJ. 2009;  338
• 5 Enck P. Der Placeboeffekt in der Medizin.  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009;  52 635-642
• 6 Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses.  Neuron. 2008;  59 195-205
• 7 Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.  BMJ. 2008;  336 999-1003
• 8 Breidert M, Hofbauer K. Placebo: Missverständnis und Vorurteile.  Dtsch Ärzteblatt. 2009;  106 751-755
• 9 Melchart D, Streng A, Hoppe A et al. Acupuncture in patients with tension-type headache: randomised controlled trial.  BMJ. 2005;  331 376-382
• 10 Szaflarski M, Ritchey PN, Leonard AC et al. Modeling the effects of spirituality/religion on patients' perceptions of living with HIV/AIDS.  J Gen Intern Med. 2006;  21
• 11 Simpson SH, Eurich DT, Majumdar SR et al. A meta-analysis of the association between adherence to drug therapy and mortality.  BMJ. 2006;  333 15
• 12 Bengel J. Was erhält Menschen gesund? Antonovskys Modell der Salutogenese: Diskussionsstand und Stellenwert.. Köln: BzGA; 1998
• 13 Fegg MJ, Kramer M, Bausewein C, Borasio GD. Meaning in life in the Federal Republic of Germany: results of a representative survey with the schedule for meaning in life evaluation (SMiLE).  Health Qual Life Outcomes. 2007;  59-67
• 14 Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of Placebo and therapeutic efficacy.  JAMA. 2008;  299 1016-1017
• 15 Benedetti F, Amonzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.  J Neurosci. 2006;  26 12014-12022
• 16 Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear.  Nat Neurosci. 2009;  12 256-258
• 17 Vlaeyen J, Crombez G, Linton SJ. The fear avoidance model of pain: We are not there yet.  Pain. 2009;  146 222-223
• 18 Porges SW. Reciprocal influences between body and brain in the perception and expression of affect: A polyvagal perspective.. In: Fosha D, et al The healing power of emotions: Affective neuroscience, development, clinical practise.. New York: W.W. Norton & Co; 2009
• 19 Oken B. Placebo effects: clinical aspects and neurobiology.  Brain. 2008;  131 2812-2823
• 20 Peters A, Schweiger U, Pellerin L et al. The selfish brain: competition for energy recourses.  Neurosci Biobehav Rev. 2004;  28 143-180
• 21 Benedetti F. No prefrontal control, no placebo response.  Pain. 2010;  148 357-358
• 22 Robinson M. Placebo analgesia: Widening the scope of measured influences.  Pain. 2009;  144 5-6
• 23 Bootzin RR, Bailey ET. Understanding placebo, nocebo and latrogenic treatment-effects.  J Clin Psychol. 2005;  61 871-880
• 24 Roy S, Llinás R. Dynamic geometry, brain function modelling, and consciousness.  Prog Brain Res. 2008;  168 133-144
• 25 Pogosyan A, Gaynor LD, Eusebio A, Brown P. Boosting cortical activity at Beta-band-frequencies slows movement in humans.  Curr Biol. 2009;  19 1637-1641
• 26 Moncrieff J, Cohen D. How do psychiatric drugs work?.  BMJ. 2009;  338
• 27 Sheline YI, Barch DM, Price JL et al. The default mode network and self-referential processes in depression.  Proc Natl Acad Sci USA. 2009;  106 1942-1947
• 28 Schibler U. The mammalian circadian timing system: The daily rhythms of genes, cells and organs. Im Internet: http://www.molbio.unige.ch/schibler/index.php Stand 10 02: 2010
• 29 Fleck S, Jäger H, Zeeb H. Travel and health status: a survey follow up study.  Eur J Public Health. 2006;  16 96-100
• 30 Burchard GD, Caumes E, Connor BA et al. Expert opinion on vaccination of travellers against Japanese encephalitis.  J Travel Med. 2009;  16 204-216
• 31 Teitelbaum P. Expert opinion on vaccination of travelers against Japanese encephalitis.  J Travel Med. 2009;  16 441-443
• 32 Ashton-James CE, Maddux WW, Galinsky AD, Chartrand TL. Who I am depends on how I feel: The role of affect in the expression of culture.  Psychol Sci. 2009;  20 340-346
• 33 Bauer J. Prinzip Menschlichkeit – Warum wir von Natur aus kooperieren. Hamburg: Hoffmann & Campe; 2006

Korrespondenz